Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma
Authors
Keywords
DNA methylation, Osteopontin, CD133+/CD44+ cells, Cancer therapy, Hepatocellular carcinoma
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 37, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-07-31
DOI
10.1186/s13046-018-0832-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid
- (2018) Xian-Yang Qin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNMT1 Inhibition Reprograms Pancreatic Cancer Stem Cells via Upregulation of the miR-17-92 Cluster
- (2016) S. Zagorac et al. CANCER RESEARCH
- Emerging role of epithelial-mesenchymal transition in hepatic cancer
- (2016) Go J. Yoshida JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- LKB1 loss links serine metabolism to DNA methylation and tumorigenesis
- (2016) Filippos Kottakis et al. NATURE
- The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
- (2015) Vicki Plaks et al. Cell Stem Cell
- Targeting Cancer Stem Cells as a Therapeutic Approach in Liver Cancer
- (2015) Gang Zhou et al. CURRENT GENE THERAPY
- Cancer stem cells: a challenging paradigm for designing targeted drug therapies
- (2015) Ishaq N. Khan et al. DRUG DISCOVERY TODAY
- Cancer stem cells in hepatocellular carcinoma: Therapeutic implications based on stem cell biology
- (2015) Tetsuhiro Chiba et al. HEPATOLOGY RESEARCH
- Effects of 5′-azacytidine and alendronate on a hepatocellular carcinoma cell line: a proteomics perspective
- (2015) Amber Ilyas et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The cancer stem cell gamble
- (2015) J. Kaiser SCIENCE
- Cancer Stem Cells: The Promise and the Potential
- (2015) Jaffer A. Ajani et al. SEMINARS IN ONCOLOGY
- DNMT1 is essential for mammary and cancer stem cell maintenance and tumorigenesis
- (2015) Rajneesh Pathania et al. Nature Communications
- Epigenetic Targeting of Ovarian Cancer Stem Cells
- (2014) Yinu Wang et al. CANCER RESEARCH
- CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis
- (2014) Matilde Todaro et al. Cell Stem Cell
- Osteopontin-CD44 Signaling in the Glioma Perivascular Niche Enhances Cancer Stem Cell Phenotypes and Promotes Aggressive Tumor Growth
- (2014) Alexander Pietras et al. Cell Stem Cell
- Epigenetic reprogramming modulates malignant properties of human liver cancer
- (2014) Chiara Raggi et al. HEPATOLOGY
- HCC therapies—lessons learned
- (2014) Marcus-Alexander Wörns et al. Nature Reviews Gastroenterology & Hepatology
- Inversed relationship between CD44 variant and c-Myc due to oxidative stress-induced canonical Wnt activation
- (2013) Go J. Yoshida et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The future of epigenetic therapy in solid tumours—lessons from the past
- (2013) Nilofer Azad et al. Nature Reviews Clinical Oncology
- Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis
- (2013) R Raja et al. ONCOGENE
- An MAPK-dependent pathway induces epithelial-mesenchymal transition via Twist activation in human breast cancer cell lines
- (2013) Neill Y. Li et al. SURGERY
- Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation
- (2012) Maria Vinci et al. BMC BIOLOGY
- Li-Fraumeni syndrome with simultaneous osteosarcoma and liver cancer: Increased expression of a CD44 variant isoform after chemotherapy
- (2012) Go J Yoshida et al. BMC CANCER
- Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma
- (2012) Christine Guo Lian et al. CELL
- Osteopontin promoter polymorphisms at locus -443 significantly affect the metastasis and prognosis of human hepatocellular carcinoma
- (2012) Qiong-Zhu Dong et al. HEPATOLOGY
- The critical role of CD133+CD44+/high tumor cells in hematogenous metastasis of liver cancers
- (2011) Ying Hou et al. CELL RESEARCH
- CD133+ liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling
- (2011) Kwan Ho Tang et al. HEPATOLOGY
- Epigenetic regulation of cancer stem cells in liver cancer: Current concepts and clinical implications
- (2010) J.U. Marquardt et al. JOURNAL OF HEPATOLOGY
- Targeting cancer stem cells by inhibiting Wnt, Notch and Hedgehog pathways
- (2010) Naoko Takebe et al. Nature Reviews Clinical Oncology
- Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors
- (2010) Lisa A Cowan et al. Epigenomics
- Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44
- (2009) Shigeo Takaishi et al. STEM CELLS
- Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma
- (2008) Bing-Sheng Sun et al. HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started